These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10795342)

  • 21. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.
    Bill JR; Mack DG; Falta MT; Maier LA; Sullivan AK; Joslin FG; Martin AK; Freed BM; Kotzin BL; Fontenot AP
    J Immunol; 2005 Nov; 175(10):7029-37. PubMed ID: 16272364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.
    Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Fingerlin TE; Sato H; Newman LS; Maier LA
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1680-8. PubMed ID: 21471109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity.
    Rogliani P; Amicosante M; Berretta F; Dotti C; Bocchino M; O'Donnell KM; Saltini C
    Int J Immunopathol Pharmacol; 2004; 17(2 Suppl):3-10. PubMed ID: 15345185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
    Saltini C; Richeldi L; Losi M; Amicosante M; Voorter C; van den Berg-Loonen E; Dweik RA; Wiedemann HP; Deubner DC; Tinelli C
    Eur Respir J; 2001 Oct; 18(4):677-84. PubMed ID: 11716174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A genetic marker for chronic beryllium disease.
    Saltini C; Richeldi L
    Med Lav; 1995; 86(3):226-8. PubMed ID: 7565282
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
    Fontenot AP; Maier LA
    Trends Immunol; 2005 Oct; 26(10):543-9. PubMed ID: 16099719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.
    Crooks J; Mroz MM; VanDyke M; McGrath A; Schuler C; McCanlies EC; Virji MA; Rosenman KD; Rossman M; Rice C; Monos D; Fingerlin TE; Maier LA
    Occup Environ Med; 2022 Feb; 79(2):120-126. PubMed ID: 34535537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test.
    Amicosante M; Deubner D; Saltini C
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):175-9. PubMed ID: 16315779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity.
    Fontenot AP; Kotzin BL
    Tissue Antigens; 2003 Dec; 62(6):449-58. PubMed ID: 14617028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. To Be2+ or not to Be2+: immunogenetics and occupational exposure.
    Newman LS
    Science; 1993 Oct; 262(5131):197-8. PubMed ID: 8105535
    [No Abstract]   [Full Text] [Related]  

  • 31. Association between IL-1A single nucleotide polymorphisms and chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Yucesoy B; Mnatsakanova A; Slaven JE; Andrew M; Frye BL; Schuler CR; Kreiss K; Weston A
    J Occup Environ Med; 2010 Jul; 52(7):680-4. PubMed ID: 20595916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking genetic susceptibility and T cell activation in beryllium-induced disease.
    Falta MT; Bowerman NA; Dai S; Kappler JW; Fontenot AP
    Proc Am Thorac Soc; 2010 May; 7(2):126-9. PubMed ID: 20427584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell recognition in chronic beryllium disease.
    Amicosante M; Fontenot AP
    Clin Immunol; 2006 Nov; 121(2):134-43. PubMed ID: 16697706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells.
    Amicosante M; Berretta F; Franchi A; Rogliani P; Dotti C; Losi M; Dweik R; Saltini C
    Eur Respir J; 2002 Nov; 20(5):1174-8. PubMed ID: 12449171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic beryllium disease: a model of interaction between environmental exposure and genetic predisposition. Pathogenesis and clinical features (Part 2)].
    Marchand-Adam S; Guillon F; Brauner M; Valeyre D
    Rev Mal Respir; 2005 Apr; 22(2 Pt 1):271-87. PubMed ID: 16092165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.
    Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease.
    Snyder JA; Weston A; Tinkle SS; Demchuk E
    Environ Health Perspect; 2003 Nov; 111(15):1827-34. PubMed ID: 14630515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.
    Snyder JA; Demchuk E; McCanlies EC; Schuler CR; Kreiss K; Andrew ME; Frye BL; Ensey JS; Stanton ML; Weston A
    J R Soc Interface; 2008 Jul; 5(24):749-58. PubMed ID: 17956852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research to Practice Implications of High-Risk Genotypes for Beryllium Sensitization and Disease.
    Kreiss K; Fechter-Leggett ED; McCanlies EC; Schuler CR; Weston A
    J Occup Environ Med; 2016 Sep; 58(9):855-60. PubMed ID: 27414009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.
    Silveira LJ; McCanlies EC; Fingerlin TE; Van Dyke MV; Mroz MM; Strand M; Fontenot AP; Bowerman N; Dabelea DM; Schuler CR; Weston A; Maier LA
    J Immunol; 2012 Oct; 189(8):4014-23. PubMed ID: 22972925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.